RNS Number : 8637A
Arbuthnot Banking Group PLC
31 May 2023
 

 

 

 

31 May 2023

 

 

Arbuthnot Banking Group PLC

 

Total Voting Rights

 

In compliance with the FCA's Disclosure Guidance and Transparency Rules, Arbuthnot Banking Group PLC (the "Company") announced that, as at the date of this announcement, its issued Ordinary Share capital consists of 16,186,345 ordinary shares of 1p each with voting rights. This figure excludes 390,274 ordinary shares which are held in treasury and are not taken into consideration in relation to the payment of dividends and voting at shareholder meetings.

 

Therefore, the total number of voting rights in the Company is 16,186,345 and this figure may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.               

 

Enquiries:

Arbuthnot Banking Group

Sir Henry Angest, Chairman and Chief Executive

Andrew Salmon, Group Chief Operating Officer

James Cobb, Group Finance Director

 

020 7012 2400

Grant Thornton UK LLP (Nominated Adviser and

AQSE Exchange Corporate Adviser)                        

Colin Aaronson

Samantha Harrison

George Grainger

Ciara Donnelly 

 

020 7383 5100

Shore Capital (Broker)  

Daniel Bush

David Coaten

Tom Knibbs

 

020 7408 4090

H/Advisors Maitland (Financial PR)

Sam Cartwright

020 7379 5151

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRBUGDUGGDDGXL